Zheng PJ, Wang JS, Liu GF, Zhang SH, Zhang YY. Efficacy of levocetirizine for the treatment of children with allergic rhinitis: A protocol for systematic review and meta-analysis.
Medicine (Baltimore) 2020;
99:e20557. [PMID:
32502023 PMCID:
PMC7306364 DOI:
10.1097/md.0000000000020557]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND
Although previous studies have reported that levocetirizine is utilized for the treatment of children with allergic rhinitis (AR), its conclusions remain inconsistent. This study aims to evaluate the efficacy and harms of levocetirizine for children with AR.
METHODS
Electronic database sources will be undertaken from the beginning to the present: MEDLINE, EMBASE, The Cochrane Library, CINAHL, ACMD, PsycINFO, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. We will not apply any restrictions to language and publication status. We will only consider randomized controlled trials of levocetirizine for children with AR. Two authors will independently scan literature, select studies, and collect data. Study quality for each included trial will be assessed using Cochrane risk of bias tool, and statistical analysis will be conducted using RevMan 5.3 software.
RESULTS
This study will summarize the present evidence to systematically assess the efficacy and harms of levocetirizine for children with AR.
CONCLUSION
The findings of this study intent to adequately inform stakeholders or clinicians, as well as to help develop treatment guidelines.
STUDY REGISTRATION NUMBER
INPLASY202040111.
Collapse